These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15292365)

  • 1. Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome.
    Tan TM; Vanderpump M; Khoo B; Patterson M; Ghatei MA; Goldstone AP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4162-5. PubMed ID: 15292365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.
    Goldstone AP; Patterson M; Kalingag N; Ghatei MA; Brynes AE; Bloom SR; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2005 May; 90(5):2681-90. PubMed ID: 15687345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
    Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
    Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
    Goldstone AP; Holland AJ; Butler JV; Whittington JE
    Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response.
    Giménez-Palop O; Giménez-Pérez G; Mauricio D; González-Clemente JM; Potau N; Berlanga E; Trallero R; Laferrère B; Caixàs A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):198-204. PubMed ID: 17223988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY, cholecystokinin, insulin and ghrelin response to meal did not change, but mean serum levels of insulin is reduced in children with Prader-Willi syndrome.
    Paik KH; Jin DK; Lee KH; Armstrong L; Lee JE; Oh YJ; Kim S; Kwon EK; Choe YH
    J Korean Med Sci; 2007 Jun; 22(3):436-41. PubMed ID: 17596650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
    DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.
    Gumus Balikcioglu P; Balikcioglu M; Muehlbauer MJ; Purnell JQ; Broadhurst D; Freemark M; Haqq AM
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3822-31. PubMed ID: 26259133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome.
    Haqq AM; Stadler DD; Rosenfeld RG; Pratt KL; Weigle DS; Frayo RS; LaFranchi SH; Cummings DE; Purnell JQ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3573-6. PubMed ID: 12915638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperghrelinemia does not accelerate gastric emptying in Prader-Willi syndrome patients.
    Choe YH; Jin DK; Kim SE; Song SY; Paik KH; Park HY; Oh YJ; Kim AH; Kim JS; Kim CW; Chu SH; Kwon EK; Lee KH
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3367-70. PubMed ID: 15657368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome.
    De Waele K; Ishkanian SL; Bogarin R; Miranda CA; Ghatei MA; Bloom SR; Pacaud D; Chanoine JP
    Eur J Endocrinol; 2008 Oct; 159(4):381-8. PubMed ID: 18603572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial.
    Allas S; Caixàs A; Poitou C; Coupaye M; Thuilleaux D; Lorenzini F; Diene G; Crinò A; Illouz F; Grugni G; Potvin D; Bocchini S; Delale T; Abribat T; Tauber M
    PLoS One; 2018; 13(1):e0190849. PubMed ID: 29320575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome.
    Butler MG; Bittel DC; Talebizadeh Z
    J Pediatr Endocrinol Metab; 2004 Sep; 17(9):1177-84. PubMed ID: 15506676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked suppression of ghrelin concentration by insulin in Prader-willi syndrome.
    Paik KH; Lee MK; Jin DK; Kang HW; Lee KH; Kim AH; Kim C; Lee JE; Oh YJ; Kim S; Han SJ; Kwon EK; Choe YH
    J Korean Med Sci; 2007 Apr; 22(2):177-82. PubMed ID: 17449920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men.
    Schmidt JB; Gregersen NT; Pedersen SD; Arentoft JL; Ritz C; Schwartz TW; Holst JJ; Astrup A; Sjödin A
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1248-56. PubMed ID: 24735885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between fasting plasma ghrelin levels and age, body mass index (BMI), BMI percentiles, and 24-hour plasma ghrelin profiles in Prader-Willi syndrome.
    Paik KH; Jin DK; Song SY; Lee JE; Ko SH; Song SM; Kim JS; Oh YJ; Kim SW; Lee SH; Kim SH; Kwon EK; Choe YH
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3885-9. PubMed ID: 15292322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural representations of hunger and satiety in Prader-Willi syndrome.
    Hinton EC; Holland AJ; Gellatly MS; Soni S; Patterson M; Ghatei MA; Owen AM
    Int J Obes (Lond); 2006 Feb; 30(2):313-21. PubMed ID: 16276365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.